AMLX20260821P17
AMLX Aug 21 2026 17.00 Put (AMLX260821P00017000)
option OPRA

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.